Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae10212794160b34478f0d05b6ab6fd7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056 |
filingDate |
2005-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4b65d1611206c8b5dd8443583663c64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_657384d9822b8f7d47627bb517bdada1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fb3dd4882892d04478e8eedbc606f50 |
publicationDate |
2005-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005148524-A1 |
titleOfInvention |
Compositions and methods for the treatment of cancer |
abstract |
This invention relates to compositions comprising thalidomide and another anti-cancer drug which can be used in the treatment or prevention of cancer. Preferred anti-cancer drugs are topoisomerase inhibitors. A particular composition comprises thalidomide, or a pharmaceutically acceptable salt, solvate, or clathrate thereof, and irinotecan. The invention also relates to methods of treating or preventing cancer which comprise the administration of a thalidomide and another anti-cancer drug to a patient in need of such treatment or prevention. The invention further relates to methods of reducing or avoiding adverse side effects associated with the administration of chemotherapy or radiation therapy which comprise the administration of thalidomide to a patient in need of such reduction or avoidance. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11304961-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005100529-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010311683-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010120810-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10537585-B2 |
priorityDate |
2000-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |